BioSpace News Archive

Vystar Corp. (Vystar) (OTCQB Market: VYST) announced today that its Board of Directors has approved a plan to spin-off part of its RxAir air purification business as a separate, independent, publicly traded company.

Hollister Incorporated, an independent, employee-owned company that develops, manufactures, and markets healthcare products worldwide is pleased to announce a $100,000 commitment to support University of Alabama Adapted Athletics.

Apexigen, Inc. announced today that Xiaodong Yang, M.D., Ph.D., President & Chief Executive Officer, will present at the upcoming Solebury Trout Private Company Showcase at the offices of Davis Polk & Wardwell, LLP in New York on Friday, October 18, 2019 at 11:40am EDT.

Enzychem Lifesciences, a leading global biopharmaceutical company focusing on innovative new drug development for unmet medical needs, today announced that three abstracts have been accepted for poster presentation at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics, on October 26-30, 2019, at the Hynes Convention Center in Boston, Massachusetts.

Most primary care physicians (62%) fear the opioid drug crisis will be traded for a new prescription drug crisis and nearly three quarters (72%) worry that chronic pain patients will turn to illicit drugs if they do not have access to prescription opioids, according to a new Health Trends™ report from Quest Diagnostics (NYSE: DGX)

PetaGene announced today that their PetaSuite software has been selected to compress the genomics data sets for AstraZeneca’s Centre for Genomics Research (CGR).

Hospitals and health systems looking to establish brand dominance, competitive distinction and clinical excellence in diabetes care can turn to a team of experts at Glytec dedicated to helping facilitate full adoption of best practices.

The Center for Innovative GYN Care® (CIGC®) co-founders, Dr. Paul MacKoul and Dr. Natalya Danilyants announced today that a Company abstract has been accepted for a presentation at this year’s ASRM Scientific Congress and Expo.

Mycovia Pharmaceuticals, Inc. today announced it has entered into an exclusive license and development and technology transfer agreement with Gedeon Richter Plc., based in Budapest, Hungary, to commercialize and manufacture VT-1161 in Europe, Latin America, Australia, Russia and other CIS countries. VT-1161, an oral antifungal product candidate, is currently in Phase 3 clinical trials for the treatment of Recurrent Vulvovaginal Candidiasis (RVVC)

Noblegen Inc., an advanced nutritional ingredient company, is excited to announce that Brendan Brazier, the co-founder of Vega, best-selling author of the Thrive book series, and editor in chief of Alive magazine, has joined Noblegen as their VP of Food Architecture.